Aurinia Pharmaceuticals
AUPH
#4605
Rank
A$3.14 B
Marketcap
A$23.82
Share price
2.65%
Change (1 day)
50.43%
Change (1 year)

Market capitalization of Aurinia Pharmaceuticals (AUPH)

Market cap: A$3.14 Billion

As of December 2025 Aurinia Pharmaceuticals has a market cap of A$3.14 Billion. This makes Aurinia Pharmaceuticals the world's 4605th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Aurinia Pharmaceuticals from 2009 to 2025

End of year Market Cap

Year Marketcap Change
2025A$3.14 B48.31%
2024A$2.11 B11.76%
2023A$1.89 B110.05%
2022A$0.90 B-77.95%
2021A$4.09 B80.46%
2020A$2.26 B-29.47%
2019A$3.21 B288.64%
2018A$0.82 B68.75%
2017A$0.49 B323.6%
2016A$0.11 B4.08%
2015A$0.11 B-20.03%
2014A$0.13 B172.12%
2013A$51.07 M397.78%
2012A$10.26 M-48.54%
2011A$19.93 M-50.08%
2010A$39.93 M73.38%
2009A$23.03 M

End of Day market cap according to different sources

On Dec 11th, 2025 the market cap of Aurinia Pharmaceuticals was reported to be:

A$3.14 Billion
by Nasdaq info icon info icon
A$3.14 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regeneron Pharmaceuticals
REGN
A$118.74 B 3,680.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
A$26.27 M-99.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
A$26.93 M-99.14%๐Ÿ‡บ๐Ÿ‡ธ USA